Replies to post #76097 on PharmaCyte Biotech Inc (PMCB)

[PINKribbon]

Dug a little deeper this morning and learned that Janssen terminated that Hanmi biologic drug trial for the treatment of diabetes due to what seemed to have been quality and/or quantity issues in manufacturing.

Janssen to restart clinical trials of Hanmi’s diabetes drug candidate
http://www.koreaherald.com/view.php?ud=20170609000639

Initiating new trial
https://clinicaltrials.gov/ct2/results?cond=Diabetes&term=JNJ-64565111&cntry1=&state1=&Search=Search